Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment
Identifieur interne : 004432 ( Main/Merge ); précédent : 004431; suivant : 004433Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment
Auteurs : David N. Finegold ; Catherine J. Baty ; Kelly Z. Knickelbein ; Shelley Perschke ; Sarah E. Noon ; Diana Campbell ; Jenny M. Karlsson ; Diana Huang ; Mark A. Kimak ; Elizabeth C. Lawrence ; Eleanor Feingold ; Stephen D. Meriney ; Adam M. Brufsky ; Robert E. FerrellSource :
- Clinical cancer research : an official journal of the American Association for Cancer Research [ 1078-0432 ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Analyse de séquence d'ADN, Cellules HeLa, Connexines (génétique), Facteurs de risque, Femelle, Humains, Jeune adulte, Lignée cellulaire tumorale, Lymphoedème (génétique), Lymphoedème (traitement médicamenteux), Prédisposition génétique à une maladie, Sujet âgé, Sujet âgé de 80 ans ou plus, Séquence nucléotidique, Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Tumeurs du sein (génétique), Tumeurs du sein (traitement médicamenteux), Études cas-témoins.
- MESH :
- anatomopathologie : Tumeurs du sein.
- génétique : Connexines, Lymphoedème, Tumeurs du sein.
- traitement médicamenteux : Lymphoedème, Tumeurs du sein.
- Adulte, Adulte d'âge moyen, Analyse de séquence d'ADN, Cellules HeLa, Facteurs de risque, Femelle, Humains, Jeune adulte, Lignée cellulaire tumorale, Prédisposition génétique à une maladie, Sujet âgé, Sujet âgé de 80 ans ou plus, Séquence nucléotidique, Tumeurs du sein, Études cas-témoins.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Base Sequence, Breast Neoplasms (drug therapy), Breast Neoplasms (genetics), Breast Neoplasms (pathology), Breast Neoplasms (surgery), Case-Control Studies, Cell Line, Tumor, Connexins (genetics), Female, Genetic Predisposition to Disease, HeLa Cells, Humans, Lymphedema (drug therapy), Lymphedema (genetics), Middle Aged, Risk Factors, Sequence Analysis, DNA, Young Adult.
- MESH :
- chemical , genetics : Connexins.
- drug therapy : Breast Neoplasms, Lymphedema.
- genetics : Breast Neoplasms, Lymphedema.
- pathology : Breast Neoplasms.
- surgery : Breast Neoplasms.
- Adult, Aged, Aged, 80 and over, Base Sequence, Case-Control Studies, Cell Line, Tumor, Female, Genetic Predisposition to Disease, HeLa Cells, Humans, Middle Aged, Risk Factors, Sequence Analysis, DNA, Young Adult.
Abstract
Secondary lymphedema is a frequent complication of breast cancer associated with surgery, chemotherapy, or radiation following breast cancer treatment. The potential contribution of genetic susceptibility to risk of developing secondary lymphedema following surgical trauma, radiation, and other tissue insults has not been studied.
To determine if women with breast cancer and secondary lymphedema had mutations in candidate lymphedema genes, we undertook a case - control study of 188 women diagnosed with breast cancer recruited from the University of Pittsburgh Breast Cancer Program (
Candidate lymphedema genes,
Cx47 mutations were identified in individuals having secondary lymphedema following breast cancer treatment but not in breast cancer controls or normal women without breast cancer. These novel mutations are dysfunctional as assessed through in vitro assays and bioinformatics analysis, and provide evidence that altered gap junction function leads to lymphedema.
Our findings challenge the view that secondary lymphedema is solely due to mechanical trauma and support the hypothesis that genetic susceptibility is an important risk factor for secondary lymphedema. A priori recognition of genetic risk 1) raises the potential for early detection and intervention for a high risk group, and 2) allows the possibility of altering surgical approach and/or chemo- and radiation therapy, or direct medical treatment of secondary lymphedema with novel connexin modifying drugs.
Secondary lymphedema is a frequent and serious chronic complication of breast cancer treatment. Our finding of four independent mutations in Cx47, including one shared mutation previously reported in primary lymphedema, not only supports these mutations as a genetic risk to the development of secondary lymphedema but raises the likelihood that other genes may contribute to such a genetic risk to secondary lymphedema as well.
Url:
DOI: 10.1158/1078-0432.CCR-11-2303
PubMed: 22351697
PubMed Central: 3625665
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 003A21
- to stream Pmc, to step Curation: 003A20
- to stream Pmc, to step Checkpoint: 002A84
- to stream PubMed, to step Corpus: 002260
- to stream PubMed, to step Curation: 002260
- to stream PubMed, to step Checkpoint: 002260
- to stream Ncbi, to step Merge: 004B01
- to stream Ncbi, to step Curation: 004B01
- to stream Ncbi, to step Checkpoint: 004B01
Links to Exploration step
PMC:3625665Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment</title>
<author><name sortKey="Finegold, David N" sort="Finegold, David N" uniqKey="Finegold D" first="David N." last="Finegold">David N. Finegold</name>
<affiliation><nlm:aff id="A1">University of Pittsburgh School of Medicine, Department of Pediatrics</nlm:aff>
<wicri:noCountry code="subfield">Department of Pediatrics</wicri:noCountry>
</affiliation>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Baty, Catherine J" sort="Baty, Catherine J" uniqKey="Baty C" first="Catherine J." last="Baty">Catherine J. Baty</name>
<affiliation><nlm:aff id="A2">University of Pittsburgh School of Medicine Department of Cell Biology & Physiology</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Knickelbein, Kelly Z" sort="Knickelbein, Kelly Z" uniqKey="Knickelbein K" first="Kelly Z." last="Knickelbein">Kelly Z. Knickelbein</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Perschke, Shelley" sort="Perschke, Shelley" uniqKey="Perschke S" first="Shelley" last="Perschke">Shelley Perschke</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Noon, Sarah E" sort="Noon, Sarah E" uniqKey="Noon S" first="Sarah E." last="Noon">Sarah E. Noon</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Campbell, Diana" sort="Campbell, Diana" uniqKey="Campbell D" first="Diana" last="Campbell">Diana Campbell</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Karlsson, Jenny M" sort="Karlsson, Jenny M" uniqKey="Karlsson J" first="Jenny M." last="Karlsson">Jenny M. Karlsson</name>
<affiliation><nlm:aff id="A2">University of Pittsburgh School of Medicine Department of Cell Biology & Physiology</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Huang, Diana" sort="Huang, Diana" uniqKey="Huang D" first="Diana" last="Huang">Diana Huang</name>
<affiliation><nlm:aff id="A2">University of Pittsburgh School of Medicine Department of Cell Biology & Physiology</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Kimak, Mark A" sort="Kimak, Mark A" uniqKey="Kimak M" first="Mark A." last="Kimak">Mark A. Kimak</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Lawrence, Elizabeth C" sort="Lawrence, Elizabeth C" uniqKey="Lawrence E" first="Elizabeth C." last="Lawrence">Elizabeth C. Lawrence</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Feingold, Eleanor" sort="Feingold, Eleanor" uniqKey="Feingold E" first="Eleanor" last="Feingold">Eleanor Feingold</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Meriney, Stephen D" sort="Meriney, Stephen D" uniqKey="Meriney S" first="Stephen D." last="Meriney">Stephen D. Meriney</name>
<affiliation><nlm:aff id="A4">University of Pittsburgh Department of Neuroscience</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Brufsky, Adam M" sort="Brufsky, Adam M" uniqKey="Brufsky A" first="Adam M." last="Brufsky">Adam M. Brufsky</name>
<affiliation><nlm:aff id="A5">University of Pittsburgh School of Medicine, Department of Medicine</nlm:aff>
<wicri:noCountry code="subfield">Department of Medicine</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Ferrell, Robert E" sort="Ferrell, Robert E" uniqKey="Ferrell R" first="Robert E." last="Ferrell">Robert E. Ferrell</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">22351697</idno>
<idno type="pmc">3625665</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625665</idno>
<idno type="RBID">PMC:3625665</idno>
<idno type="doi">10.1158/1078-0432.CCR-11-2303</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">003A21</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003A21</idno>
<idno type="wicri:Area/Pmc/Curation">003A20</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003A20</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002A84</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002A84</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">002260</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002260</idno>
<idno type="wicri:Area/PubMed/Curation">002260</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002260</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002260</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002260</idno>
<idno type="wicri:Area/Ncbi/Merge">004B01</idno>
<idno type="wicri:Area/Ncbi/Curation">004B01</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004B01</idno>
<idno type="wicri:doubleKey">1078-0432:2012:Finegold D:connexin:mutations:increase</idno>
<idno type="wicri:Area/Main/Merge">004432</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment</title>
<author><name sortKey="Finegold, David N" sort="Finegold, David N" uniqKey="Finegold D" first="David N." last="Finegold">David N. Finegold</name>
<affiliation><nlm:aff id="A1">University of Pittsburgh School of Medicine, Department of Pediatrics</nlm:aff>
<wicri:noCountry code="subfield">Department of Pediatrics</wicri:noCountry>
</affiliation>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Baty, Catherine J" sort="Baty, Catherine J" uniqKey="Baty C" first="Catherine J." last="Baty">Catherine J. Baty</name>
<affiliation><nlm:aff id="A2">University of Pittsburgh School of Medicine Department of Cell Biology & Physiology</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Knickelbein, Kelly Z" sort="Knickelbein, Kelly Z" uniqKey="Knickelbein K" first="Kelly Z." last="Knickelbein">Kelly Z. Knickelbein</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Perschke, Shelley" sort="Perschke, Shelley" uniqKey="Perschke S" first="Shelley" last="Perschke">Shelley Perschke</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Noon, Sarah E" sort="Noon, Sarah E" uniqKey="Noon S" first="Sarah E." last="Noon">Sarah E. Noon</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Campbell, Diana" sort="Campbell, Diana" uniqKey="Campbell D" first="Diana" last="Campbell">Diana Campbell</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Karlsson, Jenny M" sort="Karlsson, Jenny M" uniqKey="Karlsson J" first="Jenny M." last="Karlsson">Jenny M. Karlsson</name>
<affiliation><nlm:aff id="A2">University of Pittsburgh School of Medicine Department of Cell Biology & Physiology</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Huang, Diana" sort="Huang, Diana" uniqKey="Huang D" first="Diana" last="Huang">Diana Huang</name>
<affiliation><nlm:aff id="A2">University of Pittsburgh School of Medicine Department of Cell Biology & Physiology</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Kimak, Mark A" sort="Kimak, Mark A" uniqKey="Kimak M" first="Mark A." last="Kimak">Mark A. Kimak</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Lawrence, Elizabeth C" sort="Lawrence, Elizabeth C" uniqKey="Lawrence E" first="Elizabeth C." last="Lawrence">Elizabeth C. Lawrence</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Feingold, Eleanor" sort="Feingold, Eleanor" uniqKey="Feingold E" first="Eleanor" last="Feingold">Eleanor Feingold</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Meriney, Stephen D" sort="Meriney, Stephen D" uniqKey="Meriney S" first="Stephen D." last="Meriney">Stephen D. Meriney</name>
<affiliation><nlm:aff id="A4">University of Pittsburgh Department of Neuroscience</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Brufsky, Adam M" sort="Brufsky, Adam M" uniqKey="Brufsky A" first="Adam M." last="Brufsky">Adam M. Brufsky</name>
<affiliation><nlm:aff id="A5">University of Pittsburgh School of Medicine, Department of Medicine</nlm:aff>
<wicri:noCountry code="subfield">Department of Medicine</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Ferrell, Robert E" sort="Ferrell, Robert E" uniqKey="Ferrell R" first="Robert E." last="Ferrell">Robert E. Ferrell</name>
<affiliation><nlm:aff id="A3">University of Pittsburgh Graduate School of Public Health Department of Human Genetics</nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">Clinical cancer research : an official journal of the American Association for Cancer Research</title>
<idno type="ISSN">1078-0432</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Base Sequence</term>
<term>Breast Neoplasms (drug therapy)</term>
<term>Breast Neoplasms (genetics)</term>
<term>Breast Neoplasms (pathology)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Case-Control Studies</term>
<term>Cell Line, Tumor</term>
<term>Connexins (genetics)</term>
<term>Female</term>
<term>Genetic Predisposition to Disease</term>
<term>HeLa Cells</term>
<term>Humans</term>
<term>Lymphedema (drug therapy)</term>
<term>Lymphedema (genetics)</term>
<term>Middle Aged</term>
<term>Risk Factors</term>
<term>Sequence Analysis, DNA</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de séquence d'ADN</term>
<term>Cellules HeLa</term>
<term>Connexines (génétique)</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Lignée cellulaire tumorale</term>
<term>Lymphoedème (génétique)</term>
<term>Lymphoedème (traitement médicamenteux)</term>
<term>Prédisposition génétique à une maladie</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Séquence nucléotidique</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (anatomopathologie)</term>
<term>Tumeurs du sein (génétique)</term>
<term>Tumeurs du sein (traitement médicamenteux)</term>
<term>Études cas-témoins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Connexins</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Breast Neoplasms</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Connexines</term>
<term>Lymphoedème</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lymphoedème</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Base Sequence</term>
<term>Case-Control Studies</term>
<term>Cell Line, Tumor</term>
<term>Female</term>
<term>Genetic Predisposition to Disease</term>
<term>HeLa Cells</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Risk Factors</term>
<term>Sequence Analysis, DNA</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de séquence d'ADN</term>
<term>Cellules HeLa</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Lignée cellulaire tumorale</term>
<term>Prédisposition génétique à une maladie</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Séquence nucléotidique</term>
<term>Tumeurs du sein</term>
<term>Études cas-témoins</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Purpose</title>
<p id="P2">Secondary lymphedema is a frequent complication of breast cancer associated with surgery, chemotherapy, or radiation following breast cancer treatment. The potential contribution of genetic susceptibility to risk of developing secondary lymphedema following surgical trauma, radiation, and other tissue insults has not been studied.</p>
</sec>
<sec id="S2"><title>Experimental Design</title>
<p id="P3">To determine if women with breast cancer and secondary lymphedema had mutations in candidate lymphedema genes, we undertook a case - control study of 188 women diagnosed with breast cancer recruited from the University of Pittsburgh Breast Cancer Program (<ext-link ext-link-type="uri" xlink:href="http://www.upmccancercenter.com/breast/index.cfm">http://www.upmccancercenter.com/breast/index.cfm</ext-link>
) between 2000–2010.</p>
<p id="P4">Candidate lymphedema genes, <italic>GJC2</italic>
(encoding connexin 47 [Cx47]), <italic>FOXC2</italic>
, <italic>HGF</italic>
, <italic>MET</italic>
, and <italic>FLT4</italic>
(encoding VEGFR3), were sequenced for mutation. Bioinformatics analysis and in vitro functional assays were used to confirm significance of novel mutations.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P5">Cx47 mutations were identified in individuals having secondary lymphedema following breast cancer treatment but not in breast cancer controls or normal women without breast cancer. These novel mutations are dysfunctional as assessed through in vitro assays and bioinformatics analysis, and provide evidence that altered gap junction function leads to lymphedema.</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P6">Our findings challenge the view that secondary lymphedema is solely due to mechanical trauma and support the hypothesis that genetic susceptibility is an important risk factor for secondary lymphedema. A priori recognition of genetic risk 1) raises the potential for early detection and intervention for a high risk group, and 2) allows the possibility of altering surgical approach and/or chemo- and radiation therapy, or direct medical treatment of secondary lymphedema with novel connexin modifying drugs.</p>
</sec>
<sec id="S5"><title>Translational Relevance</title>
<p id="P7">Secondary lymphedema is a frequent and serious chronic complication of breast cancer treatment. Our finding of four independent mutations in Cx47, including one shared mutation previously reported in primary lymphedema, not only supports these mutations as a genetic risk to the development of secondary lymphedema but raises the likelihood that other genes may contribute to such a genetic risk to secondary lymphedema as well.</p>
</sec>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004432 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 004432 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Merge |type= RBID |clé= PMC:3625665 |texte= Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:22351697" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |